TheraCell Announces Royalty Milestone From Licensing

TheraCell Demineralized Bone Fiber

TheraCell announced that as of September 2020, its royalty income from licensees of its base demineralized bone fiber technology has surpassed a $1 million annual run rate. With consistent quarter over quarter growth, this achievement represents a 55% increase over the annual run rate observed at the same time last year.

TheraCell has...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us